Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


NGS for Drugs, Patients and Clinical Trials

21 Mar 2013 - 22 Mar 2013 - San Diego, CA, USA



Bookmark and Share


Next-Generation Sequencing (NGS) is poised to revolutionize the drug discovery paradigm by offering unprecedented interrogation of the human genome at high resolution and relatively low costs. While the widespread implementation of NGS is apparent, issues specific to drug development present new challenges for developers.  Join Cambridge Healthtech Institute for NGS for Drugs, Patients and Clinical Trials and explore the unparalleled advantages and arising challenges in using NGS technologies for translational research.                                                                                                                                                           

Discussions will cover:

  • NGS for Decision Making During Drug Development and Clinical Trials
  • Developing Informatics Infrastructure & Pipelines to Handle Complex NGS Data
  • Navigating Regulatory Hurdles of Informed Consent and Data Sharing
  • Harnessing NGS Technologies for Identification of Causal Variants and "Driver" Mechanisms in Disease

Featured presentations include:

Profiling and NGS in Cancer: Challenges and Applications to Targets, Models, and Resistance

Paul Rejto, Ph.D., Director, Computational Biology, Oncology Research Unit, Pfizer, Inc.


Devising Methods for Intuitively Handling Huge Data Sets to Simplify Biomarker Discovery

Dongliang Ge, Ph.D., Director, Bioinformatics, Gilead Sciences, Inc.



Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!